SearchDictionaryMobileLogin Register FREE

Osteoarticular Tuberculosis

312  relevant articles (1 outcomes, 14 trials/studies) found for this Disease

Description: Tuberculosis of the bones or joints.

Also Known As:
Tuberculosis, Osteoarticular; Bone Tuberculoses; Joint Tuberculoses; Osteoarticular Tuberculoses; Tuberculoses, Bone; Tuberculoses, Joint; Tuberculoses, Osteoarticular; Tuberculosis, Bone; Tuberculosis, Joint; Bone Tuberculosis; Joint Tuberculosis

Relationship Network

Disease Context: Research Results

Related Diseases

1. Tuberculosis
2. Pulmonary Tuberculosis (Phthisis)
3. Meningeal Tuberculosis (Tuberculous Meningitis)
4. Lymphatic Diseases (Lymphadenopathy)
5. Infection
36 Diseases and 45 more articles analyzed in the Research Interface, order at left...

Experts

1. van Hellemondt, G G: 1 article (08/2008)
2. Vreeling, A W J: 1 article (08/2008)
3. de Haan, J: 1 article (08/2008)
4. Kumar, S: 1 article (03/2003)
5. Harinath, B C: 1 article (03/2003)
6. Banerjee, S: 1 article (03/2003)
7. Strzalkowski, J: 1 article (11/2002)
8. Filewska, M: 1 article (11/2002)
9. Demkow, U: 1 article (11/2002)
10. Nowak-Misiak, M: 1 article (11/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Osteoarticular Tuberculosis:
1. Isoniazid (Ftivazide)FDA LinkGeneric
2. IproniazidIBA
3. Streptomycin (Streptomycin Sulfate)FDA Link
4. Rifampin (Rifampicin)FDA LinkGeneric
5. AntibodiesIBA
10/01/1959 - "Electrophoretic study on blood antibodies in osteoarticular tuberculosis.]"
06/01/1998 - "METHOD: Antibodies in sera from 75 patients with active bone and joint tuberculosis, 69 patients with non-tuberculous bone and joint diseases and 72 healthy individuals were detected by the rapid immunochromatographic assay using ICT-TB kit"
06/01/1992 - "We discuss the case of a 22-year-old female, carrying of antibodies to against human immunodeficiency virus (HIV), who developed several tumors on different bone localizations, which corresponded to plurifocal bone tuberculosis"
04/01/2003 - "This study is of interest that different antigen protein fractions of M.tb exhibit differential seroreactivity, as ES-31 protein showed good potential in detecting tuberculous IgG antibodies in tuberculous lymphadenopathy (TBLN) & tuberculous meningitis (TBM), while ES-41 in abdominal and bone & joint tuberculosis cases."
06/01/2001 - "Two different excretory-secretory antigenic proteins of M.tbH37Ra viz., EST-DE1 (a 6% TCA soluble and DEAE anion exchange purified antigen) and ESAS-7 (50% ammonium sulphate solubilized and SDS-PAGE fractionated antigen) were studied in stick-indirect penicillinase ELISA for detecting tuberculous IgG antibodies in serum samples of pulmonary as well as extrapulmonary tuberculosis (tuberculous lymphadenopathy (TBLN), tuberculous meningitis (TBM), bone & joint tuberculosis (B&J TB), abdominal tuberculosis (Abd"
Get all the results and reference details, order at left...
6. p-Aminosalicylic Acid (PAS)FDA Link
7. AntigensIBA
8. Thioacetazone (Thiacetazone)IBA
9. Antitubercular AgentsIBA
10. Immunoglobulin G (IgG)IBA
04/01/2003 - "In abdominal and bone & joint tuberculosis cases, ES-41 antigen showed better sensitivity of 81.5% (22/27) and 84.6% (22/26) respectively in IgG antibody detection compared to 70% (19/27) and 69.2% (18/26) shown by ES-31"
06/01/2001 - "In histopathologically proven bone and joint tuberculosis and abdominal tuberculosis cases EST-DE1 antigen showed better sensitivity of 75% and 83.3% respectively in IgG antibody detection compared to that of ESAS-7 antigen (50% and 66% respectively)"
04/01/2003 - "This study is of interest that different antigen protein fractions of M.tb exhibit differential seroreactivity, as ES-31 protein showed good potential in detecting tuberculous IgG antibodies in tuberculous lymphadenopathy (TBLN) & tuberculous meningitis (TBM), while ES-41 in abdominal and bone & joint tuberculosis cases."
03/01/2000 - "Fifty patients of bone and joint tuberculosis (age 15-70 years) and 30 healthy controls were studied for levels of immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), T cells and circulating immune complexes (CICs) in different stages of disease"
06/01/2001 - "Two different excretory-secretory antigenic proteins of M.tbH37Ra viz., EST-DE1 (a 6% TCA soluble and DEAE anion exchange purified antigen) and ESAS-7 (50% ammonium sulphate solubilized and SDS-PAGE fractionated antigen) were studied in stick-indirect penicillinase ELISA for detecting tuberculous IgG antibodies in serum samples of pulmonary as well as extrapulmonary tuberculosis (tuberculous lymphadenopathy (TBLN), tuberculous meningitis (TBM), bone & joint tuberculosis (B&J TB), abdominal tuberculosis (Abd"
Get all the results and reference details, order at left...
87 Drugs and Important Bio-Agents and 227 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Anesthesia
3. Arthroplasty
4. Heliotherapy
5. Prostheses and Implants (Prosthesis)
30 Therapies and Procedures and 95 more articles analyzed in the Research Interface, order at left...

Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License details >>
Price:$490.00 access via web interface, 1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m", 1 year subscription
Proceed to Checkout >>